[] [RULE 13a-14(a) CERTIFICATION FOR FORM 10-Q (CEO) CERTIFICATION I, Yongke Xue, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Future FinTech Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a materia]
[Number Page 1.1 Announcement of interim results for the six months ended 30 June 2018, dated August 20, 2018 A-1 6-K our business and operating strategies and our ability to successfully execute these strategies; our network expansion and capital expenditure plans; our operations and business ]
[This Form 6-K consists of: THE OBJECTIVES OF THE COMPANY As a power company, devoted to providing sufficient, reliable and eco-friendly energy to the community; as a listed company, devoted to creating long-term, stable and increasing returns for shareholders; and as a first class power producer, de]
[FORM 10−Q (Mark One) [X] For the quarterly period ended: June 30, 2018 [ ] For the transition period from _____________ to _____________ 001-32898 CBAK ENERGY TECHNOLOGY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) BAK In]
[www.umc.com Description 99.1 Announcement on 2018/08/20: Important Resolutions from UMC’s 2018 First Extraordinary General Meeting 99.2 Announcement on 2018/08/20: UMC’s 2018 First Extraordinary General Meeting has approved to release the Director from non-competition restrictions 1 Important Resolu]
[SEC Concludes Investigation of Sinovac About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical Company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccine]
[FORM 10−Q (Mark One) [X] For the quarterly period ended: June 30, 2018 [ ] For the transition period from _____________ to _____________ 001-32898 CBAK ENERGY TECHNOLOGY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) BAK In]
[SEC Concludes Investigation of Sinovac About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical Company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccine]
[Dunxin Financial Holdings Limited Reports Financial Results for the First Six Months of 2018 WUHAN, HUBEI, China—August 20, 2018—Dunxin Financial Holdings Limited (“Dunxin” or the “Company”) (NYSE American: DXF), a leading licensed microfinance lender serving individuals and small and medium enterpr]
[www.umc.com Description 99.1 Announcement on 2018/08/20: Important Resolutions from UMC’s 2018 First Extraordinary General Meeting 99.2 Announcement on 2018/08/20: UMC’s 2018 First Extraordinary General Meeting has approved to release the Director from non-competition restrictions 1 Important Resolu]
